DK0994713T3 - Anvendelse af et 7alpha-methyl-17alpha-ethynyl-estranderivat til behandling af atherosklerose - Google Patents

Anvendelse af et 7alpha-methyl-17alpha-ethynyl-estranderivat til behandling af atherosklerose

Info

Publication number
DK0994713T3
DK0994713T3 DK98912450T DK98912450T DK0994713T3 DK 0994713 T3 DK0994713 T3 DK 0994713T3 DK 98912450 T DK98912450 T DK 98912450T DK 98912450 T DK98912450 T DK 98912450T DK 0994713 T3 DK0994713 T3 DK 0994713T3
Authority
DK
Denmark
Prior art keywords
7alpha
17alpha
ethynyl
atherosclerosis
methyl
Prior art date
Application number
DK98912450T
Other languages
Danish (da)
English (en)
Inventor
Dirk Gerrit Meuleman
Pieter Zandberg
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0994713T3 publication Critical patent/DK0994713T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98912450T 1997-03-05 1998-03-03 Anvendelse af et 7alpha-methyl-17alpha-ethynyl-estranderivat til behandling af atherosklerose DK0994713T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97200646 1997-03-05
PCT/EP1998/001293 WO1998039012A1 (en) 1997-03-05 1998-03-03 USE OF A 7α-METHYL-17α-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS

Publications (1)

Publication Number Publication Date
DK0994713T3 true DK0994713T3 (da) 2004-03-08

Family

ID=8228079

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98912450T DK0994713T3 (da) 1997-03-05 1998-03-03 Anvendelse af et 7alpha-methyl-17alpha-ethynyl-estranderivat til behandling af atherosklerose

Country Status (21)

Country Link
EP (1) EP0994713B1 (de)
JP (1) JP2001515478A (de)
KR (1) KR100556558B1 (de)
CN (1) CN1159014C (de)
AR (1) AR015371A1 (de)
AT (1) ATE253366T1 (de)
AU (1) AU733758B2 (de)
BR (1) BR9808194A (de)
CA (1) CA2283418A1 (de)
DE (1) DE69819503T2 (de)
DK (1) DK0994713T3 (de)
ES (1) ES2210731T3 (de)
HK (1) HK1025510A1 (de)
HU (1) HUP0001499A3 (de)
IL (1) IL123422A (de)
NO (1) NO994305L (de)
PL (1) PL335904A1 (de)
TR (1) TR199902510T2 (de)
TW (1) TW448049B (de)
WO (1) WO1998039012A1 (de)
ZA (1) ZA981731B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834931A1 (de) * 1998-07-28 2000-02-24 Jenapharm Gmbh Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie
TW577893B (en) * 1998-10-16 2004-03-01 Akzo Nobel Nv High purity composition comprising (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one

Also Published As

Publication number Publication date
TW448049B (en) 2001-08-01
HK1025510A1 (en) 2000-11-17
DE69819503T2 (de) 2004-09-23
DE69819503D1 (de) 2003-12-11
IL123422A0 (en) 1998-09-24
CN1159014C (zh) 2004-07-28
HUP0001499A2 (hu) 2000-11-28
HUP0001499A3 (en) 2001-03-28
BR9808194A (pt) 2000-05-16
KR20000075966A (ko) 2000-12-26
AU733758B2 (en) 2001-05-24
KR100556558B1 (ko) 2006-03-06
JP2001515478A (ja) 2001-09-18
AU6728498A (en) 1998-09-22
CN1252723A (zh) 2000-05-10
EP0994713A1 (de) 2000-04-26
CA2283418A1 (en) 1998-09-11
TR199902510T2 (xx) 2000-02-21
NO994305D0 (no) 1999-09-03
WO1998039012A1 (en) 1998-09-11
PL335904A1 (en) 2000-05-22
ZA981731B (en) 1998-09-07
ES2210731T3 (es) 2004-07-01
ATE253366T1 (de) 2003-11-15
NO994305L (no) 1999-11-01
IL123422A (en) 2003-05-29
AR015371A1 (es) 2001-05-02
EP0994713B1 (de) 2003-11-05

Similar Documents

Publication Publication Date Title
DE69823725D1 (de) Selbstexpandierendes Medizingerät
NO954290D0 (no) Festeanordning for protese
DE59802830D1 (de) Orthesengelenk
DE69530614D1 (de) Iontophorese pflaster
DK0880892T5 (da) Midler med reguleret frigivelse
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
EE9800454A (et) Steroidsed bisfosfonaadid
DK199801279A (da) Fremgangsmåde til belægning af medicinske kanyler
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK0777804T3 (da) Indretning til et stillads
DK0994713T3 (da) Anvendelse af et 7alpha-methyl-17alpha-ethynyl-estranderivat til behandling af atherosklerose
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
NO993549L (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
DK0956019T3 (da) Hidtil ukendt terapeutisk anvendelse af et thienylcyclohexaminderivat
ATE215947T1 (de) Piperidinylmethyloxazolidinon-derivat
DE59804807D1 (de) Pi-komplex-verbindungen
PT950051E (pt) Forma em microparticulas de um derivado de tetra-hidropiridina
DK1015442T3 (da) Fremgangsmåde til fremstilling af 3-isochromanon
DK1000052T3 (da) Fremgangsmåde til fremstilling af 3-isochromanon
ATA128198A (de) Dusche
FI974544A0 (fi) Anordning i en med manoeverplats foersedd lastkran
DK1051401T3 (da) Fremgangsmåde til fremstilling af formylimidazoler
DK0882035T3 (da) Fremgangsmåde til fremstilling af 2H-1-benzopyraner
IT242723Y1 (it) Impalcatura perfezionata